ID   MB-1 [Human thyroid carcinoma]
AC   CVCL_2109
SY   MB1
DR   BioSample; SAMN03473455
DR   cancercelllines; CVCL_2109
DR   Cell_Model_Passport; SIDM01639
DR   DepMap; ACH-001356
DR   DSMZ; ACC-638
DR   DSMZCellDive; ACC-638
DR   Wikidata; Q54904088
RX   PubMed=18616678;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=18616678); ~60-100 hours (DSMZ=ACC-638).
CC   Karyotypic information: Has lost chromosome Y (PubMed=18616678).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): DepMap=ACH-001356; DSMZ=ACC-638
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 19
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 20
ST   D3S1358: 14
ST   D5S818: 10
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 15
ST   Penta E: 13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
RX   PubMed=18616678; DOI=10.1111/j.1349-7006.2008.00882.x; PMCID=PMC11158382;
RA   Stenner, Frank
RA   Liewen, Heike
RA   Zweifel, Martin
RA   Weber, Achim
RA   Tchinda, Joelle
RA   Bode, Beata
RA   Samaras, Panagiotis
RA   Bauer, Stefan
RA   Knuth, Alexander
RA   Renner, Christoph
RT   "Targeted therapeutic approach for an anaplastic thyroid cancer in
RT   vitro and in vivo.";
RL   Cancer Sci. 99:1847-1852(2008).
//